Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E V Høgdall

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 29, 1999
Alpha-fetoprotein in human fetal cerebrospinal fluidM Christiansen, C K Høgdall, E V Høgdall
Ugeskrift for Laeger|June 20, 1994
[Screening of newborn infants for cystic fibrosis. A combined analysis of immunoreactive trypsin and delta F508 mutation--a screening without false positive results]B Nørgaard-Pedersen, E V Høgdall, J Arends, et al.
Thrombosis Research|August 15, 1992
Changes in plasma tetranectin following hip surgery with or without thrombotic complicationsC K Høgdall, E V Høgdall, L N Jørgensen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1991
Tetranectin in amniotic fluid, maternal serum and fetal fluidsE V Høgdall, C K Høgdall, I Clemmensen, et al.
European Journal of Biochemistry|March 10, 1998
Structure and tissue-specific expression of genes encoding bovine copper amine oxidasesE V Høgdall, G Houen, M Borre, et al.
European Journal of Gynaecological Oncology|December 5, 2006
Do risk factors for epithelial ovarian cancer have an impact on prognosis? Focus on previous pelvic surgery and reproductive variablesA Kjaerbye-Thygesen, K Frederiksen, E V Høgdall, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1993
Pre-operative plasma tetranectin as a prognostic marker in ovarian cancer patientsC K Høgdall, E V Høgdall, U Hørding, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|August 16, 2000
Stability of YKL-40 concentration in blood samplesE V Høgdall, J S Johansen, S K Kjaer, et al.
Prenatal Diagnosis|March 1, 1992
CA-125 as a maternal serum marker for Down's syndrome in the first and second trimestersC K Høgdall, E V Høgdall, J Arends, et al.
Gynecologic Oncology|November 1, 1991
Plasma tetranectin and ovarian neoplasmsC K Høgdall, E V Høgdall, U Hørding, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 29, 1999
Alpha-fetoprotein in human fetal cerebrospinal fluidM Christiansen, C K Høgdall, E V Høgdall
Ugeskrift for Laeger|June 20, 1994
[Screening of newborn infants for cystic fibrosis. A combined analysis of immunoreactive trypsin and delta F508 mutation--a screening without false positive results]B Nørgaard-Pedersen, E V Høgdall, J Arends, et al.
Thrombosis Research|August 15, 1992
Changes in plasma tetranectin following hip surgery with or without thrombotic complicationsC K Høgdall, E V Høgdall, L N Jørgensen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 1991
Tetranectin in amniotic fluid, maternal serum and fetal fluidsE V Høgdall, C K Høgdall, I Clemmensen, et al.
European Journal of Biochemistry|March 10, 1998
Structure and tissue-specific expression of genes encoding bovine copper amine oxidasesE V Høgdall, G Houen, M Borre, et al.
European Journal of Gynaecological Oncology|December 5, 2006
Do risk factors for epithelial ovarian cancer have an impact on prognosis? Focus on previous pelvic surgery and reproductive variablesA Kjaerbye-Thygesen, K Frederiksen, E V Høgdall, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1993
Pre-operative plasma tetranectin as a prognostic marker in ovarian cancer patientsC K Høgdall, E V Høgdall, U Hørding, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|August 16, 2000
Stability of YKL-40 concentration in blood samplesE V Høgdall, J S Johansen, S K Kjaer, et al.
Prenatal Diagnosis|March 1, 1992
CA-125 as a maternal serum marker for Down's syndrome in the first and second trimestersC K Høgdall, E V Høgdall, J Arends, et al.
Gynecologic Oncology|November 1, 1991
Plasma tetranectin and ovarian neoplasmsC K Høgdall, E V Høgdall, U Hørding, et al.
Pageof 2